Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
The potent antiangiogenic pigment epithelium-derived factor (PEDF) has shown promise against osteosarcoma, a tumour that originates in the bone and metastasises to the lungs. Neurotrophic, antiangiogenic, antiproliferative, and antimetastatic properties of PEDF have been attributed to a number of fu...
| Main Authors: | Broadhead, M., Choong, P., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
Hindawi Publishing Corporation
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/40859 |
Similar Items
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)
by: Chandolu, V., et al.
Published: (2012)
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)
by: Choong, P., et al.
Published: (2011)
Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)
by: Lee, P., et al.
Published: (2016)
Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012)
by: Elahy, Mina, et al.
Published: (2012)
PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)
by: Carnagarin, Revathy, et al.
Published: (2015)
Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
by: Elahy, M., et al.
Published: (2014)
by: Elahy, M., et al.
Published: (2014)
Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Osteosarcoma in neonate with rare liver metastasis and abdominal lymphadenopathy
by: Mohamad Sani, Suraini, et al.
Published: (2018)
by: Mohamad Sani, Suraini, et al.
Published: (2018)
Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)
by: Carnagarin, R., et al.
Published: (2018)
PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)
by: Carnagarin, R., et al.
Published: (2015)
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)
by: Alcantara, M., et al.
Published: (2013)
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
by: Clark, J., et al.
Published: (2010)
by: Clark, J., et al.
Published: (2010)
RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)
by: Akiyama, T., et al.
Published: (2010)
Pigment Epithelium-Derived Factor as an Impending Therapeutic Agent Against Vascular Epithelial Growth Factor-Driven Tumor-Angiogenesis
by: Manalo, K., et al.
Published: (2011)
by: Manalo, K., et al.
Published: (2011)
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)
by: Xiao, S., et al.
Published: (2015)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)
by: Alcantara, M., et al.
Published: (2014)
Efficacy of antibacterial peptides against peptide-resistant mrsa is restored by permeabilization of bacteria membranes
by: Ravensdale, J., et al.
Published: (2016)
by: Ravensdale, J., et al.
Published: (2016)
Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)
by: Ouyang, Z., et al.
Published: (2018)
Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)
by: Selvarajah, Gayathri Thevi
Published: (2011)
Novel synthetic antimicrobial peptides with In-Vivo and In-Vitro activity against Streptococcus Pneumoniae / Le Cheng Foh
by: Le, Cheng Foh
Published: (2013)
by: Le, Cheng Foh
Published: (2013)
Screening of Broad-Spectrum Antibacterial Effects of Synthetic Peptide Pam-5 against Selected Pathogenic Bacteria
by: Chan, Szn Yi
Published: (2016)
by: Chan, Szn Yi
Published: (2016)
Screening for antibacterial activity of 15-MER linear synthetic peptide PAM-6 against Pseudomonas aeruginosa
by: Chen, Pei Fei
Published: (2015)
by: Chen, Pei Fei
Published: (2015)
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Pericytes in Metastasis
by: Pieterse, Z., et al.
Published: (2019)
by: Pieterse, Z., et al.
Published: (2019)
Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens
by: Tan, Wen Siang
Published: (2002)
by: Tan, Wen Siang
Published: (2002)
Metastasis within a metastasis to the thyroid: A rare phenomenon
by: Wong, Yin PIng, et al.
Published: (2017)
by: Wong, Yin PIng, et al.
Published: (2017)
Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse islets
by: Chen, Y., et al.
Published: (2016)
by: Chen, Y., et al.
Published: (2016)
Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)
by: Indumathy, S., et al.
Published: (2013)
Mild hyperthermia (39°C) attenuates berberine chloride
cytotoxicity against osteosarcoma cells
by: Mohammed Ali Nashiry,, et al.
Published: (2019)
by: Mohammed Ali Nashiry,, et al.
Published: (2019)
In vitro evaluation of a novel pH sensitive drug delivery system based cockle shell-derived aragonite nanoparticles against osteosarcoma
by: Fu, Wenliang, et al.
Published: (2017)
by: Fu, Wenliang, et al.
Published: (2017)
Similar Items
-
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011) -
The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010) -
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012) -
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010) -
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)